M. Speck, H. Kurreck, M. O. Senge
FULL PAPER
thane/n-hexane ϭ 70:30. Purple crystals, m.p. Ͼ 330 °C. Ϫ 1H 585 nm (3.52). Ϫ MS; m/z (%): 752 [M ϩ 2]•ϩ (1), 751 [M ϩ 1]•ϩ
3
NMR (CDCl3): δ ϭ 8.92 (4 H, AB, J ϭ 4.6 Hz, β-pyrrole), 8.89
(2 H, d, 3J ϭ 4.7 Hz, β-pyrrole), 8.85 (2 H, d, 3J ϭ 4.7 Hz, β-
pyrrole), 8.33Ϫ8.29 (2 H, m, o-phenyl), 8.28Ϫ8.25 (1 H, m, o-
phenyl), 8.19Ϫ8.13 (3 H, m, o-phenyl), 7.78Ϫ7.69 (9 H, m, m- and
p-phenyl), 7.59 (1 H, s, arom.), 4.14 (3 H, s, ϪOMe), 4.13 (3 H, s,
ϪOMe), 1.39 (9 H, s, tBu), 0.72 (9 H, s, tBu). Ϫ 13C NMR
(CDCl3): δ ϭ 153.50, 153.19, 151.26, 150.08, 150.00, 149.99,
142.88, 142.83, 142.81, 136.92, 134.78, 134.50, 134.45, 134.36,
134.28, 132.16, 131.82, 131.72, 129.83, 127.42, 126.52, 126.50,
124.64, 120.96, 120.76, 59.80, 59.54, 37.73, 34.67, 32.38, 30.69. Ϫ
UV/Vis (CH2Cl2): λmax (lg ε) ϭ 422 (5.59), 513 (3.41), 551 (4.27),
591 nm (3.50). Ϫ MS; m/z (%): 850 [M ϩ 2]•ϩ (83), 849 [M ϩ 1]•ϩ
(73), 848 [M]•ϩ (100), 791 [M Ϫ Zn]•ϩ (6), 57 [C4H9]ϩ (9). Ϫ
HRMS: calcd. for C54H48O2N4Zn 848.30687; found 848.30662.
(1), 750 [M]•ϩ (1), 44 [C2H4O]ϩ (100). Ϫ HRMS: calcd. for
C47H34O2N4Zn 750.19732; found 750.19744.
{5-(2,3-Dimethoxyphenyl)-10,15,20-triphenylporphyrinato}zinc(II)
(20): Free base 15 (34 mg) was treated according to Method A and
gave red-purple crystals. Ϫ HPLC: n-hexane/ethyl acetate ϭ 85:15.
1
Ϫ M.p. Ͼ 330 °C. Ϫ H NMR (CDCl3): δ ϭ 8.95, 8.92 (8 H, AB,
β-pyrrole), 8.28Ϫ8.18 (6 H, m, o-phenyl), 7.80Ϫ7.71 (9 H, m, m-
and p-phenyl), 7.67 (1 H, dd, 3J ϭ 7.5 Hz, 4J ϭ 1.5 Hz, arom.),
7.38 (1 H, dd, 3J ϭ 8.4 Hz, 3J ϭ 7.5 Hz, arom.), 7.32 (1 H, dd,
3J ϭ 8.4 Hz, 4J ϭ 1.5 Hz, arom.), 4.09 (3 H, s, ϪOMe), 3.21 (3 H, s,
ϪOMe). Ϫ 13C NMR (CDCl3): δ ϭ 152.20, 150.24, 150.16, 149.98,
149.46, 142.85, 142.81, 136.88, 134.45, 134.42, 132.16, 131.92,
131.84, 131.66, 127.86, 127.41, 126.50, 121.92, 121.24, 120.96,
116.25, 112.44, 60.80, 56.02. Ϫ UV/Vis (CH2Cl2): λmax (rel. int.) ϭ
419 (1.000), 511 (0.006), 547 (0.039), 584 nm (0.007). Ϫ MS; m/z
(%): 738 [M ϩ 2]•ϩ (68), 737 [M ϩ 1]•ϩ (50), 736 [M]•ϩ (100), 721
[M Ϫ CH3]•ϩ (7). Ϫ HRMS: calcd. for C46H32O2N4Zn 736.18167;
found 736.18196.
{5-(2,5-Dimethyl-3,4-dimethoxyphenyl)-10,15,20-triphenyl-
porphyrinato}zinc(II) (17): Free base porphyrin 12 (35 mg) was
treated according to Method A and yielded the zinc(II) complex as
red-purple crystals. Ϫ HPLC: n-hexane/ethyl acetate ϭ 92:8, m.p.
Ͼ 330 °C. Ϫ 1H NMR (CDCl3): δ ϭ 8.92 (4 H, AB, β-pyrrole),
3
8.90 (2 H, d, 3J ϭ 4.7 Hz, β-pyrrole), 8.84 (2 H, d, J ϭ 4.7 Hz, β-
Synthesis of the Zinc(II) Complexes of the Demethylation Products
of 11: For preparation of larger amounts of the zinc(II) complexes
of the tert-butylated porphyrin-o-quinone 1 and its decomposition
products 32 and 33, the mixture resulting from the demethylation
of 11 was treated with zinc(II) acetate according to Method A. As
all products were stable compounds, the individual zinc(II) com-
plexes could be separated from each other by HPLC. Ϫ The zinc-
(II) complexes could also be prepared from the individual free base
porphyrins. During metallation of the diketone 32 two different
metal complexes [the (E) and (Z) stereoisomers] were formed (1:3.2
ratio). The (Z) isomer 43 could be obtained in its pure form by
treating the mixture with light for 2 d.[41] HPLC: n-hexane/ethyl
acetate ϭ 90:10.
pyrrole), 8.25Ϫ8.17 (6 H, m, o-phenyl), 7.78Ϫ7.70 (9 H, m, m- and
p-phenyl), 7.60 (1 H, q, 4J ϭ 1.9 Hz, arom.), 4.14 (3 H, s, ϪOMe),
4.06 (3 H, s, ϪOMe), 2.44 (3 H, s, ϪMe), 1.89 (3 H, s, ϪMe). Ϫ
13C NMR (CDCl3): δ ϭ 151.19, 150.42, 150.22, 150.16, 150.14,
150.12, 142.80, 142.75, 138.14, 134.43, 134.37, 132.11, 131.91,
131.83, 131.65, 131.55, 127.45, 127.04, 126.52, 120.10, 120.94,
119.73, 60.51, 60.49, 15.92, 14.63. Ϫ UV/Vis (CH2Cl2): λmax (lg
ε) ϭ 419 (5.69), 510 (3.46), 548 (4.32), 584 nm (3.52). Ϫ MS; m/z
(%): 766 [M ϩ 2]•ϩ (73), 765 [M ϩ 1]•ϩ (59), 764 [M]•ϩ (100), 749
[M Ϫ CH3]•ϩ (6), 719 [M Ϫ 3 CH3]•ϩ (10), 662 (20), 530 (23),
382 (9), 57 (45). Ϫ HRMS: calcd. for C48H36O2N4Zn 764.21297;
found 764.21557.
{5-(3,6-Di-tert-butyl-1,2-dioxocyclohexa-3,5-dien-4-yl)-10,15,20-
triphenylporphyrinato}zinc(II) (6): Reddish brown crystals, m.p.
{5-(3,4-Dimethoxyphenyl)-10,15,20-triphenylporphyrinato}zinc(II)
(18): The zinc(II) complex was prepared using 34 mg of the dime-
thoxyporphyrin 13 and following Method A. HPLC: n-hexane/
3
183Ϫ185 °C. Ϫ 1H NMR (CDCl3): δ ϭ 9.30 (2 H, d, J ϭ 4.5 Hz,
β-pyrrole), 9.05 (2 H, d, 3J ϭ 4.5 Hz, β-pyrrole), 8.94 (4 H, AB,
3J ϭ 4.5 Hz, β-pyrrole), 8.34Ϫ8.29 (2 H, m, o-phenyl), 8.28Ϫ24 (1
H, m, o-phenyl), 8.18Ϫ8.10 (3 H, m, o-phenyl), 7.83Ϫ7.70 (9 H,
m, m- and p-phenyl), 7.58 (1 H, s, quinoid), 1.22 (9 H, s, tBu), 0.69
(9 H, s, tBu). Ϫ 13C NMR (CDCl3): δ ϭ 185.26, 181.80, 150.61,
150.56, 150.32, 148.72, 148.67, 147.01, 143.47, 142.44, 142.33,
142.32, 134.42, 134.35, 134.26, 133.21, 132.39, 129.72, 127.71,
127.64, 126.69, 126.64, 126.61, 121.98, 121.57, 118.73, 37.82, 34.70,
30.98, 29.16. Ϫ UV/Vis (CH2Cl2): λmax (lg ε) ϭ 418 (5.42), 553
(3.99), 597 nm (3.42). Ϫ MS; m/z (%): 820 [M ϩ 2]•ϩ (6), 819 [M
ϩ 1]•ϩ (1), 818 [M]•ϩ (2), 792 [M Ϫ CO]•ϩ (22), 708 [M Ϫ 2 CO
ϪC4H8]•ϩ (12), 191 (100). Ϫ HRMS: calcd. for C52H42O2N4Zn
818.25992; found 818.25968.
1
ethyl acetate ϭ 84:16. Purple crystals, m.p. Ͼ 330 °C. Ϫ H NMR
3
(CDCl3): δ ϭ 8.92 (2 H, AB, J ϭ 4.7 Hz, β-pyrrole), 8.89Ϫ84 (6
H, AB, s, β-pyrrole), 8.16Ϫ8.10 (6 H, m, o-phenyl), 7.72 (1 H, d,
3J ϭ 2.0 Hz, arom.), 7.70Ϫ7.62 (9 H, m, m- and p-phenyl), 7.69 (1
H, arom.), 7.13 (1 H, d, 3J ϭ 8.1 Hz, arom.), 4.06 (3 H, s, ϪOMe),
3.87 (3 H, s, ϪOMe). Ϫ 13C NMR (CDCl3): δ ϭ 150.44, 150.18,
150.15, 148.55, 146.80, 142.75, 135.36, 134.38, 131.98, 127.47,
127.16, 126.53, 121.12, 121.10, 120.88, 118.09, 109.23, 56.08, 56.04.
Ϫ UV/Vis (CH2Cl2): λmax (rel. int.) ϭ 420 (1.000), 511 (0.008), 547
(0.050), 586 nm (0.010). Ϫ MS; m/z (%): 738 [M ϩ 2]•ϩ (72), 737
[M ϩ 1]•ϩ (51), 736 [M]•ϩ (100), 721 [M Ϫ CH3]•ϩ (5), 368 [M]•ϩϩ
(8).
Ϫ HRMS: calcd. for C46H32O2N4Zn 736.18167; found
736.18153.
{5-(2,3-Dimethoxy-4-methylphenyl)-10,15,20-triphenyl-
porphyrinato}zinc(II) (19): The substituted dimethoxyporphyrin
(34 mg) was treated with zinc(II) acetate according to Method A.
Ϫ HPLC: n-hexane/ethyl acetate ϭ 90:10. Red-purple crystals, m.p.
{5-(3,6-Di-tert-butyl-2,7-dihydro-2,7-dioxooxepin-4-yl)-10,15,20-
triphenylporphyrinato}zinc(II) (39): Purple crystals, m.p. Ͼ 330 °C.
Ϫ H NMR (CDCl3): δ ϭ 9.20 (2 H, br. s, β-pyrrole), 9.04 (2 H,
1
3
3
d, J ϭ 4.7 Hz, β-pyrrole), 8.94 (4 H, AB, J ϭ 4.7 Hz, β-pyrrole),
Ͼ 330 °C. Ϫ 1H NMR (CDCl3): δ ϭ 8.95 (8 H, AB, β-pyrrole), 8.35Ϫ8.30 (2 H, m, o-phenyl), 8.30Ϫ8.26 (1 H, m, o-phenyl),
8.26Ϫ8.21 (3 H, m, o-phenyl), 8.21Ϫ8.17 (3 H, m, o-phenyl),
7.75Ϫ7.66 (9 H, m, m- and p-phenyl), 7.76 (1 H, d, arom.), 7.20 (1 phenyl), 7.26 (1 H, s, olef.), 1.23 (9 H, s, tBu), 0.71 (9 H, s, tBu).
H, d, 3J ϭ 7.6 Hz, arom.), 4.01 (3 H, s, ϪOMe), 3.20 (3 H, s, 13C NMR (CDCl3): δ ϭ 163.97, 162.35, 150.51, 150.34, 150.13,
ϪOMe), 2.55 (3 H, s, ϪMe). Ϫ 13C NMR (CDCl3): δ ϭ 153.29, 146.91, 142.45, 142.30, 141.13, 137.36, 134.44, 134.41, 134.35,
8.15Ϫ8.09 (3 H, m, o-phenyl), 7.84Ϫ7.69 (9 H, m, m- and p-
Ϫ
150.81, 150.45, 150.22, 150.19, 150.06, 142.80, 134.82, 134.42,
134.40, 132.65, 132.23, 131.95, 131.91, 131.67, 130.25, 127.46,
134.35, 134.25, 133.24, 132.36, 132.25, 130.09, 127.69, 127.63,
126.65, 126.59, 122.13, 121.50, 113.67, 37.53, 36.14, 30.31, 29.01.
126.52, 123.84, 121.27, 121.03, 116.57, 60.76, 60.47, 16.30. Ϫ UV/ Ϫ UV/Vis (CH2Cl2): λmax (rel. int.) ϭ 421 (1.000), 513 (0.006), 549
Vis (CH2Cl2): λmax (lg ε) ϭ 419 (5.76), 511 (3.46), 547 (4.34),
(0.041), 588 nm (0.007). Ϫ MS; m/z (%): 836 [M ϩ 2]•ϩ (1), 835 [M
2312
Eur. J. Org. Chem. 2000, 2303Ϫ2314